Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Identification and Pharmacological Profile of a New Class of Selective Nicotinic Acetylcholine Receptor Potentiators
- L. Broad, R. Zwart, E. Sher
- Biology, ChemistryJournal of Pharmacology and Experimental…
- 1 September 2006
Three novel (2-amino-5-keto)thiazole compounds that act as selective potentiators of nicotinic acetylcholine receptors are discovered, which should help in clarifying the potential therapeutic utility of selective nAChR modulation for the treatment of central nervous system disorders.
Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands.
- P. Astles, S. Baker, J. Boot, L. Broad, C. Dell, M. Keenan
- Biology, ChemistryCurrent drug targets. CNS and neurological…
- 31 July 2002
The first 1000 fold selective low molecular weight ligands from the AstraZeneca group are described and the first subtype specific channel modulators are commented on.
Innovative drug development for headache disorders: glutamate
ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia
Effects of Ca2+ and Na+ channel inhibitors in vitro and in global cerebral ischaemia in vivo.
Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia
LY290181, an Inhibitor of Diabetes-Induced Vascular Dysfunction, Blocks Protein Kinase C—Stimulated Transcriptional Activation Through Inhibition of Transcription Factor Binding to a Phorbol Response…
The results suggest that LY290181 may inhibit diabetes-induced vascular dysfunction by inhibiting transcription factor binding to specific PKC-regulated genes involved in vascular function.
Inhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran.
- T. Wiernicki, J. Bean, J. P. Singh
- Biology, ChemistryThe Journal of pharmacology and experimental…
- 1 September 1996
It is demonstrated that naphthopyrans LY290181 and LY290293 are potent inhibitors of smooth muscle cell proliferation in vitro and that they produce substantial reduction in arterial intimal thickening in a balloon injury model when administered systemically.
Oxidative 5-endo cyclization of enamides mediated by ceric ammonium nitrate.
The methodology was used to synthesize the basic heterocyclic ring fragments of the natural products L-755,807, Quinolacticin C, and PI-091.